InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Kerr Douglas, Chief Medical Officer. Officer active across 2 companies, notably Dyne Therapeutics, Inc.. Aggregated, 16 disclosures have been logged. Breakdown: 0 buy · 4 sells. Total volume traded: €64k. Activity tracked since 8 July 2021. The latest transaction was filed on 13 May 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Declarations16 total
887 sharesCommon StockSEC:0001814189-26-000002:0
1,564 shares@ US$18.360.0009% mcap50.0% of flowCommon StockSEC:0001193125-26-223966
1,564 shares@ US$18.360.0009% mcap50.0% of flowCommon StockSEC:0001193125-26-223966:0
1,343 shares@ US$11.8323.4% of flowCommon StockSEC:0000950170-25-035499:0
48,000 shares0Common StockSEC:0000950170-24-134073:0
47,500 shares0Common StockSEC:0000950170-24-103037:0
5,021 sharesCommon StockSEC:0001415889-24-002073:0
7,437 sharesCommon StockSEC:0001415889-24-001334:0
7,437 sharesCommon StockSEC:0001415889-23-014357:0
7,437 sharesCommon StockSEC:0001415889-23-011232:0
7,437 sharesCommon StockSEC:0001415889-23-006595:0
7,438 sharesCommon StockSEC:0001415889-23-001072:0
7,438 sharesCommon StockSEC:0001415889-22-010645:0
14,876 sharesCommon StockSEC:0001415889-22-007766:0
3,518 shares@ US$5.1650.0% of flowCommon StockSEC:0001415889-21-003583
3,518 shares@ US$5.1650.0% of flowCommon StockSEC:0001415889-21-003583:0
16 of 16 declarations
About Kerr Douglas
Douglas Kerr is the Chief Medical Officer at Dyne Therapeutics, Inc. and Generation Bio Co. He is responsible for medical strategy and overseeing clinical programs. His expertise is crucial for the development of innovative treatments.
